FdaApplication
ANDA 210681
Identifiers
- fda_app_no: ANDA210681
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2018-11-23 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RANITIDINE HYDROCHLORIDE | RANITIDINE HYDROCHLORIDE | EQ 300MG BASE | CAPSULE;ORAL |
| RANITIDINE HYDROCHLORIDE | RANITIDINE HYDROCHLORIDE | EQ 150MG BASE | CAPSULE;ORAL |
2 products